GHK-Cu + Niacinamide (Vitamin B3) Synergy: By co-encapsulating these two powerhouse ingredients, we address barrier function and collagen synthesis simultaneously
The SOUL trial tested oral semaglutide in people with type 2 diabetes who were at high cardiovascular risk
Nearly two-thirds (64%) of adults were overweight or obese in England in 2022
IND-enabling toxicology studies are still ongoing, with an IND filing and a phase 1 SAD/MAD trial expected in the first half of 2026
NexLife names six: 503A Empower Houston, TX 503A Strive Gilbert, AZ 503A Hallandale Hallandale Beach, FL 503B Medivera FDA-registered 503B Absolute FDA-registered 503B RedRock FDA-registered The dual 503A + 503B partnership matters: as shortage status and regulatory frameworks shift, having both pathways keeps the supply chain robust
The Elithair approach: when does a hair transplant make sense